Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -2178.90% is 65% above its 5-year average of -6242.92%, near the high end of its 5-year range (-107798.33%–5042.01%).
9.09% below its 12-month average of -1997.42%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2047.61%.
NET PROFIT MARGIN
-2178.90%
NET PROFIT MARGIN AVG TTM
-1997.42%
NET PROFIT MARGIN AVG 3Y
-6049.88%
NET PROFIT MARGIN AVG 5Y
-6242.92%
NET PROFIT MARGIN AVG 10Y
-2113.22%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-9.09%
CURRENT VS 3Y AVG
+63.98%
CURRENT VS 5Y AVG
+65.10%
CURRENT VS 10Y AVG
-3.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-837938.46%
vs the sector median at left
Ovid Therapeutics Inc.
Market Cap
$442.34M
Net Profit Margin
-2178.90%
TTM Avg
-1997.42%
3Y Avg
-6049.88%
5Y Avg
-6242.92%
Market Cap
$439.55M
Net Profit Margin
-0.06%
TTM Avg
-74.67%
3Y Avg
-251.03%
5Y Avg
-526.51%
Market Cap
$445.71M
Net Profit Margin
0.00%
TTM Avg
-90.86%
3Y Avg
-351.90%
5Y Avg
-2330.90%
Market Cap
$438.07M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$435.61M
Net Profit Margin
-1392.61%
TTM Avg
-834.59%
3Y Avg
-416.33%
5Y Avg
-277.55%
Market Cap
$431.97M
Net Profit Margin
-19.34%
TTM Avg
-27.72%
3Y Avg
-52.31%
5Y Avg
-58.02%
Market Cap
$426.51M
Net Profit Margin
-184.24%
TTM Avg
-97.14%
3Y Avg
-46011.59%
5Y Avg
-30736.66%
Market Cap
$424.10M
Net Profit Margin
-6.77%
TTM Avg
-13.38%
3Y Avg
-17.48%
5Y Avg
-11.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | $442.34M | -2178.90% | -1997.42% | -6049.88% | -6242.92% |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.55M | -0.06% | -74.67% | -251.03% | -526.51% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 0.00% | -90.86% | -351.90% | -2330.90% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $438.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| YD Bio Limited Ordinary Shares (YDES)vs › | $435.61M | -1392.61% | -834.59% | -416.33% | -277.55% |
| NRC Health (NRC)vs › | $452.54M | 4.18% | 12.88% | 16.89% | 20.14% |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | -19.34% | -27.72% | -52.31% | -58.02% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | -184.24% | -97.14% | -46011.59% | -30736.66% |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | -6.77% | -13.38% | -17.48% | -11.79% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-585.2%
Net Profit Margin
-2178.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2047.61% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 1345.82% |
| 2025-09-30 | -9210.61% |
| 2025-06-30 | -74.68% |
| 2025-03-31 | -7873.08% |
| 2024-12-31 | -12175.00% |
| 2024-09-30 | -8095.95% |
| 2024-06-30 | 5042.01% |
| 2024-03-31 | -7901.35% |
| 2023-12-31 | -10790.14% |
| 2023-09-30 | -10323.85% |
| 2023-06-30 | -16544.00% |
| 2023-03-31 | -20236.36% |
| 2022-12-31 | -24859.09% |
| 2022-09-30 | -107798.33% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -1114.46% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 84.46% |
| 2020-12-31 | -386.27% |
| 2020-09-30 | -237.56% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
